The Huntington's Disease Treatment Market is estimated to be valued at US$380.3 million in 2022 and is expected to exhibit a CAGR of 23.20% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Huntington's disease is a hereditary neurological disorder that leads to the progressive degeneration of nerve cells in the brain....
Market drivers The high unmet medical needs of Huntington's disease patients is a major growth driver for this market. Currently available treatments only provide symptomatic relief and do not halt or reverse the progression of the disease. This has accelerated research focus towards developing transformational gene therapies and pharmacological interventions. Rising healthcare expenditures per...
Huntington's disease (HD) is a rare and devastating genetic neurodegenerative disorder that affects the central nervous system. It is characterized by progressive motor, cognitive, and psychiatric symptoms, leading to severe disability and reduced life expectancy. Historically, there has been no cure for HD, and treatment options have been limited to managing symptoms. However, in recent years,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian